Trials / Completed
CompletedNCT02467257
Gum Arabic as Fetal Hemoglobin Agent in Sickle Cell Anemia
Potential Role of Gum Arabic as Fetal Hemoglobin Agent in Sudanese Sickle Cell Anemia Patients
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 47 (actual)
- Sponsor
- Al-Neelain University · Academic / Other
- Sex
- All
- Age
- 5 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether Gum Arabic is effective as fetal hemoglobin inducing agent for sickle cell anemia patients.
Detailed description
: High level of fetal haemoglobin (Hb F) decreases sickle cell anaemia (SCA) severity and leads to improved survival. Butyrate proved to increase HbF production in vivo and in vitro studies. Nonetheless, its short half-life limited its utilization in clinical practice. Gum Arabic (GA) is edible, dried, gummy exudate from Acacia Senegal tree. GA fermentation by colonic bacteria increases serum butyrate concentrations. The investigators hypothesized regular intake of GA will increase serum butyrate level. The latter will induce fetal hemoglobin production and ameliorate patients' symptoms. 47 patients hemoglobin SS aged 5-42 years, on regular follow up in Military hospital were recruited from April 2014 to January 2015 Patients received dose of G A 30g/day for 12 weeks. Hb F, complete blood count and Erythropoietin level were measured. The main outcome of interest was the level of HbF after 12 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Gum Arabic | oral ingestion of 30 gram every day for 12 weeks |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2015-01-01
- Completion
- 2015-01-01
- First posted
- 2015-06-10
- Last updated
- 2015-06-10
Locations
1 site across 1 country: Sudan
Source: ClinicalTrials.gov record NCT02467257. Inclusion in this directory is not an endorsement.